P.Hertsen Moscow Oncology Research Institute – branch of NMRRC of the Ministry of Health of Russia
P.Hertsen Moscow Oncology Research Institute – branch of NMRRC of the Ministry of Health of Russia was the first scientific institute in Europe specialized in oncology that provided medical care and the first oncological hospital in Russia. The Institute provides traditional and modern treatment, including surgery, radiation, chemotherapy, photodynamic therapy, combined treatments to patients with tumors of various localization; develops new methods of diagnosis and treatment programs. Our goal is to cure or considerably prolong the life of patients and to ensure best possible quality of life after treatment. Annually, P.Hertsen MORI performs more than 7000 high-tech cancer treatments and more than 5000 surgical treatments. P.Hertsen Moscow Oncology Research Institute is a reference centre in surgical oncology for medical organizations in Russia, CIS countries and Europe. Surgeons of the P.Hertsen MORI have been successfully using minimally invasive techniques in gynecologic oncology and oncourology, video-assisted thoracoscopic lobectomy/segmentectomy, gastrectomy, resection of liver and mediastinal tumors. In the breast cancer department, plastic surgeons perform immediate breast reconstruction during the same procedure as oncologic resection.
A.Tsyba Medical Radiological Research Centre - branch of NMRRC of the Ministry of Health of Russia
A.Tsyba Medical Radiological Research Centre – branch of NMRRC of the Ministry of Health of Russia – was established in 1962. It is the leading center in Russia in diagnostic radiology, radionuclide therapy, cell and molecular radiobiology in the treatment of cancer, palliative medicine and the development of new radiopharmaceuticals. The Center specializes in surgical, chemoradiotherapy and combined treatment of patients with tumors of various localization; develops and applies new methods of diagnosis and therapy that improve prognosis and quality of life after treatment. Annually, A.Tsyba MRRC provides high-tech treatments to more than 16000 patients. The Centre specializes in the following areas: proton therapy, brachytherapy, radio and chemoembolization, radionuclide therapy. The Centre is a world leader in the treatment of cancer using radiopharmaceuticals. One of the varieties of radionuclide therapy is radioiodine therapy to which there is often no alternative method for patients suffering from papillary and follicular thyroid cancer. In its clinical practice the Centre uses adoptive immunotherapy using NK cells and other cytotoxic lymphocytes. Application of adoptive immunotherapy improves the standard chemotherapy outcomes, reduces the number of postoperative complications and the number of infectious complications, improves prognosis and the quality of life of a cancer patient. This therapy is offered to otherwise non-responsive patients and can be performed at any stage of treatment.
N.Lopatkin Research Institute of Urology and Interventional Radiology – branch of the NMRRC of the Ministry of Health of Russia
If you are not a citizen of Russia and do not have a Russian medical insurance you should send a request to the patients service department by e-mail email@example.com or by phone: +7 (495) 945-83-85 on business days from 08.00 to 20.00 Moscow time. Please, enclose your medical records in the Russian language. The requests are processed within 3 working days. We will forward you preliminary treatment plan and price calculation within 3 working days upon receipt of your request.
Treatment price is determined in accordance with the price-list of the NMRRC of the Ministry of Health of Russia and its branches effective at the date of the contract signed with the patient. Provision of medical services is subject to 100% prepayment.
Additional services provided to international patients:
• meeting at the airport and special transport service;
• individual support during the whole treatment;
• translation of medical records into Russian language.
+7 (495) 945-83-85
с 8:00 до 20:00 (working days)